Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Onconetix ( (ONCO) ) is now available.
On August 6, 2025, Onconetix, Inc. issued a promissory note to Keystone Capital Partners, LLC, with a principal amount of $117,647.06, due by March 6, 2026, or earlier if sufficient proceeds are raised. The note is subordinate to existing debt obligations to Veru Inc. Additionally, Onconetix has been involved in a series of agreements with Veru Inc. regarding the purchase of Veru’s ENTADFI business assets, initially agreed upon in April 2023. Due to payment defaults, several forbearance agreements have been made, extending payment deadlines and modifying terms, with the latest amendment occurring on August 7, 2025. Furthermore, Ajit Singh resigned from the Board of Directors effective August 10, 2025.
Spark’s Take on ONCO Stock
According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.
Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.
To see Spark’s full report on ONCO stock, click here.
More about Onconetix
Average Trading Volume: 819,626
Technical Sentiment Signal: Sell
Current Market Cap: $1.48M
See more data about ONCO stock on TipRanks’ Stock Analysis page.